<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-06-16" modified="2017-09-27" version="129">
<accession>Q9BQ69</accession>
<accession>Q9UH96</accession>
<name>MACD1_HUMAN</name>
<protein>
<recommendedName>
<fullName>O-acetyl-ADP-ribose deacetylase MACROD1</fullName>
<ecNumber>3.2.2.-</ecNumber>
<ecNumber>3.5.1.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>MACRO domain-containing protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Protein LRP16</fullName>
</alternativeName>
<alternativeName>
<fullName>[Protein ADP-ribosylglutamate] hydrolase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">MACROD1</name>
<name type="synonym">LRP16</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Zhongguo Shi Yan Xue Ye Xue Za Zhi" volume="9" first="18" last="21">
<title>The application of RACE technique to clone the full-length cDNA of a novel leukemia associated gene LRP16.</title>
<authorList>
<person name="Han W.-D."/>
<person name="Yu L."/>
<person name="Lou F.D."/>
<person name="Wang Q.S."/>
<person name="Zhao Y."/>
<person name="Shi Z.J."/>
<person name="Jin H.J."/>
</authorList>
<dbReference type="PubMed" id="12578638"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Lymphocyte</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="Endocr. Relat. Cancer" volume="10" first="217" last="224">
<title>Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.</title>
<authorList>
<person name="Han W.-D."/>
<person name="Mu Y.-M."/>
<person name="Lu X.-C."/>
<person name="Xu Z.-M."/>
<person name="Li X.-J."/>
<person name="Yu L."/>
<person name="Song H.-J."/>
<person name="Li M."/>
<person name="Lu J.-M."/>
<person name="Zhao Y.-L."/>
<person name="Pan C.-Y."/>
</authorList>
<dbReference type="PubMed" id="12790785"/>
<dbReference type="DOI" id="10.1677/erc.0.0100217"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="Cell Res." volume="17" first="869" last="880">
<title>Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin.</title>
<authorList>
<person name="Meng Y.G."/>
<person name="Han W.-D."/>
<person name="Zhao Y.-L."/>
<person name="Huang K."/>
<person name="Si Y.-L."/>
<person name="Wu Z.-Q."/>
<person name="Mu Y.-M."/>
</authorList>
<dbReference type="PubMed" id="17893710"/>
<dbReference type="DOI" id="10.1038/cr.2007.79"/>
</citation>
<scope>INDUCTION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="Endocr. Relat. Cancer" volume="14" first="741" last="753">
<title>Estrogenically regulated LRP16 interacts with estrogen receptor alpha and enhances the receptor's transcriptional activity.</title>
<authorList>
<person name="Han W.-D."/>
<person name="Zhao Y.-L."/>
<person name="Meng Y.G."/>
<person name="Zang L."/>
<person name="Wu Z.-Q."/>
<person name="Li Q."/>
<person name="Si Y.-L."/>
<person name="Huang K."/>
<person name="Ba J.-M."/>
<person name="Morinaga H."/>
<person name="Nomura M."/>
<person name="Mu Y.-M."/>
</authorList>
<dbReference type="PubMed" id="17914104"/>
<dbReference type="DOI" id="10.1677/ERC-06-0082"/>
</citation>
<scope>INTERACTION WITH ESR1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="Eur. J. Haematol." volume="79" first="25" last="31">
<title>LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22).</title>
<authorList>
<person name="Imagama S."/>
<person name="Abe A."/>
<person name="Suzuki M."/>
<person name="Hayakawa F."/>
<person name="Katsumi A."/>
<person name="Emi N."/>
<person name="Kiyoi H."/>
<person name="Naoe T."/>
</authorList>
<dbReference type="PubMed" id="17532767"/>
<dbReference type="DOI" id="10.1111/j.1600-0609.2007.00858.x"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH RUNX1</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="Endocr. Relat. Cancer" volume="16" first="139" last="153">
<title>The single-macro domain protein LRP16 is an essential cofactor of androgen receptor.</title>
<authorList>
<person name="Yang J."/>
<person name="Zhao Y.-L."/>
<person name="Wu Z.-Q."/>
<person name="Si Y.-L."/>
<person name="Meng Y.G."/>
<person name="Fu X.B."/>
<person name="Mu Y.-M."/>
<person name="Han W.-D."/>
</authorList>
<dbReference type="PubMed" id="19022849"/>
<dbReference type="DOI" id="10.1677/ERC-08-0150"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ANDROGENE RECEPTOR</scope>
<scope>INDUCTION BY ANDROGEN</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2009" name="J. Endocrinol." volume="202" first="167" last="177">
<title>Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.</title>
<authorList>
<person name="Tian L."/>
<person name="Wu Z."/>
<person name="Zhao Y."/>
<person name="Meng Y."/>
<person name="Si Y."/>
<person name="Fu X."/>
<person name="Mu Y."/>
<person name="Han W."/>
</authorList>
<dbReference type="PubMed" id="19403568"/>
<dbReference type="DOI" id="10.1677/JOE-09-0054"/>
</citation>
<scope>INDUCTION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2013" name="Nat. Struct. Mol. Biol." volume="20" first="508" last="514">
<title>A family of macrodomain proteins reverses cellular mono-ADP-ribosylation.</title>
<authorList>
<person name="Jankevicius G."/>
<person name="Hassler M."/>
<person name="Golia B."/>
<person name="Rybin V."/>
<person name="Zacharias M."/>
<person name="Timinszky G."/>
<person name="Ladurner A.G."/>
</authorList>
<dbReference type="PubMed" id="23474712"/>
<dbReference type="DOI" id="10.1038/nsmb.2523"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASN-174; ASP-184 AND GLY-270</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-138</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="13261" last="13271">
<title>Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases.</title>
<authorList>
<person name="Chen D."/>
<person name="Vollmar M."/>
<person name="Rossi M.N."/>
<person name="Phillips C."/>
<person name="Kraehenbuehl R."/>
<person name="Slade D."/>
<person name="Mehrotra P.V."/>
<person name="von Delft F."/>
<person name="Crosthwaite S.K."/>
<person name="Gileadi O."/>
<person name="Denu J.M."/>
<person name="Ahel I."/>
</authorList>
<dbReference type="PubMed" id="21257746"/>
<dbReference type="DOI" id="10.1074/jbc.M110.206771"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 91-325</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF ASP-160; ASP-167; ASN-171; ASN-174; ASP-184; HIS-188; SER-268 AND GLY-270</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<comment type="function">
<text evidence="8 9 10 11 12 13">Removes ADP-ribose from glutamate residues in proteins bearing a single ADP-ribose moiety. Inactive towards proteins bearing poly-ADP-ribose. Deacetylates O-acetyl-ADP ribose, a signaling molecule generated by the deacetylation of acetylated lysine residues in histones and other proteins. Plays a role in estrogen signaling. Binds to androgen receptor (AR) and amplifies the transactivation function of AR in response to androgen. May play an important role in carcinogenesis and/or progression of hormone-dependent cancers by feed-forward mechanism that activates ESR1 transactivation. Could be an ESR1 coactivator, providing a positive feedback regulatory loop for ESR1 signal transduction. Could be involved in invasive growth by down-regulating CDH1 in endometrial cancer cells. Enhances ESR1-mediated transcription activity.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="12">Subject to competitive inhibition by the product ADP-ribose.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="12">373 uM for O-acetyl-ADP-ribose</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="9 10">Interacts with ESR1; Interacts in a manner that is estrogen independent but is enhanced by estrogen. Interacts (via macro domain) with AR.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-5324932"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13">Nucleus</location>
</subcellularLocation>
<text>Recruited to DNA lesions, probably via mono-APD-ribosylated proteins.</text>
</comment>
<comment type="induction">
<text evidence="6 8 10 11">Overexpressed by estrogens in breast cancer MCF-7 cells, probably via an activation of nuclear receptors for steroids (ESR1 but not ESR2). Significantly increased by estrogens in ESR1-positive Ishikawa endometrial cancer cells. Up-regulated in 17-beta-estradiol-responsive BG-1 ovarian cancer cells but down-regulated in estrogen-resistant SKOV3 ovarian cancer cells. Induced by androgen.</text>
</comment>
<comment type="disease">
<text evidence="7">A chromosomal aberration involving MACROD1 is found in acute leukemia. Translocation t(11;21)(q13;q22) that forms a RUNX1-MACROD1 fusion protein.</text>
</comment>
<comment type="miscellaneous">
<text>Overexpression may promote MCF-7 cells proliferation. There is an approximate one-third increase of the invasive capacity of MACROD1-overexpressing cells. The expression of CDH1 is repressed by MACROD1. Further analyzes demonstrats that MACROD1 inhibits CDH1 transactivation in a dose dependent manner. Inhibition is abolished by estrogen deprivation, indicating that the down-regulation of CDH1 transcription by MACROD1 requires ESR1 mediation. Binding of ESR1 to the CDH1 promoter is antagonized by MACROD1, suggesting that MACROD1 could interfere with ESR1-mediated transcription. Knockdown of MACROD1 leads to impaired AR function and greatly attenuates the coactivation of AR by other AR coactivators such as UXT and NCOA1. This interference also markedly inhibits the androgen-stimulated proliferation of androgen-sensitive LNCaP prostate cancer cells. MACROD1 knockdown does not significantly affect the growth rate of AR-negative PC-3 prostate cancer cells.</text>
</comment>
<comment type="sequence caution" evidence="14">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH03188" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="14">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH03188" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MACROD1ID50947ch11q13.html"/>
</comment>
<dbReference type="EC" id="3.2.2.-"/>
<dbReference type="EC" id="3.5.1.-"/>
<dbReference type="EMBL" id="AF202922">
<property type="protein sequence ID" value="AAF15294.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000270">
<property type="protein sequence ID" value="AAH00270.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003188">
<property type="protein sequence ID" value="AAH03188.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007297">
<property type="protein sequence ID" value="AAH07297.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008316">
<property type="protein sequence ID" value="AAH08316.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8056.1"/>
<dbReference type="RefSeq" id="NP_054786.2">
<property type="nucleotide sequence ID" value="NM_014067.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.602898"/>
<dbReference type="PDB" id="2X47">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=91-325"/>
</dbReference>
<dbReference type="PDBsum" id="2X47"/>
<dbReference type="ProteinModelPortal" id="Q9BQ69"/>
<dbReference type="SMR" id="Q9BQ69"/>
<dbReference type="BioGrid" id="118813">
<property type="interactions" value="30"/>
</dbReference>
<dbReference type="IntAct" id="Q9BQ69">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000255681"/>
<dbReference type="iPTMnet" id="Q9BQ69"/>
<dbReference type="PhosphoSitePlus" id="Q9BQ69"/>
<dbReference type="BioMuta" id="MACROD1"/>
<dbReference type="DMDM" id="32129719"/>
<dbReference type="EPD" id="Q9BQ69"/>
<dbReference type="MaxQB" id="Q9BQ69"/>
<dbReference type="PaxDb" id="Q9BQ69"/>
<dbReference type="PeptideAtlas" id="Q9BQ69"/>
<dbReference type="PRIDE" id="Q9BQ69"/>
<dbReference type="Ensembl" id="ENST00000255681">
<property type="protein sequence ID" value="ENSP00000255681"/>
<property type="gene ID" value="ENSG00000133315"/>
</dbReference>
<dbReference type="GeneID" id="28992"/>
<dbReference type="KEGG" id="hsa:28992"/>
<dbReference type="UCSC" id="uc001nyh.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="28992"/>
<dbReference type="DisGeNET" id="28992"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000133315.10"/>
<dbReference type="GeneCards" id="MACROD1"/>
<dbReference type="HGNC" id="HGNC:29598">
<property type="gene designation" value="MACROD1"/>
</dbReference>
<dbReference type="HPA" id="HPA041031"/>
<dbReference type="HPA" id="HPA071075"/>
<dbReference type="MIM" id="610400">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9BQ69"/>
<dbReference type="OpenTargets" id="ENSG00000133315"/>
<dbReference type="PharmGKB" id="PA162394816"/>
<dbReference type="eggNOG" id="KOG2633">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2110">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00520000055566"/>
<dbReference type="HOGENOM" id="HOG000086960"/>
<dbReference type="HOVERGEN" id="HBG052356"/>
<dbReference type="InParanoid" id="Q9BQ69"/>
<dbReference type="OMA" id="KITCGYR"/>
<dbReference type="OrthoDB" id="EOG091G0NNH"/>
<dbReference type="PhylomeDB" id="Q9BQ69"/>
<dbReference type="TreeFam" id="TF341440"/>
<dbReference type="ChiTaRS" id="MACROD1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9BQ69"/>
<dbReference type="GenomeRNAi" id="28992"/>
<dbReference type="PRO" id="PR:Q9BQ69"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000133315"/>
<dbReference type="CleanEx" id="HS_MACROD1"/>
<dbReference type="Genevisible" id="Q9BQ69">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019213">
<property type="term" value="F:deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016798">
<property type="term" value="F:hydrolase activity, acting on glycosyl bonds"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051725">
<property type="term" value="P:protein de-ADP-ribosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042278">
<property type="term" value="P:purine nucleoside metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR002589">
<property type="entry name" value="Macro_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF01661">
<property type="entry name" value="Macro"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00506">
<property type="entry name" value="A1pp"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51154">
<property type="entry name" value="MACRO"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="O-acetyl-ADP-ribose deacetylase MACROD1" id="PRO_0000084485">
<location>
<begin position="1"/>
<end position="325"/>
</location>
</feature>
<feature type="domain" description="Macro" evidence="5">
<location>
<begin position="141"/>
<end position="322"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="3">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="3">
<location>
<begin position="172"/>
<end position="174"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="3">
<location>
<begin position="179"/>
<end position="184"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="14">
<location>
<begin position="267"/>
<end position="273"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="3">
<location>
<position position="306"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form RUNX1-MACROD1" evidence="7">
<location>
<position position="100"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine" evidence="4">
<location>
<position position="96"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine" evidence="4">
<location>
<position position="103"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine" evidence="4">
<location>
<position position="129"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="163"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="2">
<location>
<position position="138"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced enzyme activity." evidence="12">
<original>D</original>
<variation>A</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced enzyme activity." evidence="12">
<original>D</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced enzyme activity. No significant effect on affinity for substrate." evidence="12">
<original>N</original>
<variation>A</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced ADP-ribosyl hydrolase activity; when associated with A-184. Reduces O-acetyl-ADP-ribose deacetylase activity by 93%; when associated with A-184. No significant effect on affinity for substrate." evidence="12 13">
<original>N</original>
<variation>A</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced ADP-ribosyl hydrolase activity; when associated with A-174. Reduces O-acetyl-ADP-ribose deacetylase activity by 93%; when associated with A-174. No significant effect on affinity for substrate." evidence="12 13">
<original>D</original>
<variation>A</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced enzyme activity." evidence="12">
<original>H</original>
<variation>A</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="mutagenesis site" description="No significant effect on enzyme activity." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity." evidence="12 13">
<original>G</original>
<variation>E</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="94"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="107"/>
<end position="110"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="122"/>
<end position="124"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="128"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="148"/>
<end position="151"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="154"/>
<end position="159"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="164"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="182"/>
<end position="191"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="193"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="210"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="218"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="237"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="261"/>
<end position="264"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="276"/>
<end position="294"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="299"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="308"/>
<end position="321"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2X47"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q922B1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00490"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12790785"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17532767"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17893710"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17914104"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19022849"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19403568"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21257746"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23474712"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000305"/>
<sequence length="325" mass="35505" checksum="82294BFC904FA4D0" modified="2003-06-16" version="2">
MSLQSRLSGRLAQLRAAGQLLVPPRPRPGHLAGATRTRSSTCGPPAFLGVFGRRARTSAG
VGAWGAAAVGRTAGVRTWAPLAMAAKVDLSTSTDWKEAKSFLKGLSDKQREEHYFCKDFV
RLKKIPTWKEMAKGVAVKVEEPRYKKDKQLNEKISLLRSDITKLEVDAIVNAANSSLLGG
GGVDGCIHRAAGPLLTDECRTLQSCKTGKAKITGGYRLPAKYVIHTVGPIAYGEPSASQA
AELRSCYLSSLDLLLEHRLRSVAFPCISTGVFGYPCEAAAEIVLATLREWLEQHKDKVDR
LIICVFLEKDEDIYRSRLPHYFPVA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>